Kira Biotech
Latest round
- Series A
Last raised
- Apr 2019
Total raised
- $11M
Investors
- 3
About Kira Biotech
Founded in 2019 and based in Brisbane, Australia, Kira Biotech Pty Ltd is a biotechnology company that develops immunomodulatory compounds for the treatment of immune system disorders. The company develops the product, KB312, an immune-cell depleting monoclonal antibody that targets activated immune cells and restores homeostasis through the induction of immune tolerance.
Who invested in Kira Biotech
3 investors across 1 round
See all investors in Kira Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 16, 2019
Amount
$11M
Investors
Questions about Kira Biotech
Who invested in Kira Biotech?
Kira Biotech has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kira Biotech raised?
Kira Biotech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Kira Biotech last raise money?
Kira Biotech's most recent round on record is a Series A, in Apr 2019.
What does Kira Biotech do?
Founded in 2019 and based in Brisbane, Australia, Kira Biotech Pty Ltd is a biotechnology company that develops immunomodulatory compounds for the treatment of immune system disorders.
Where is Kira Biotech headquartered?
Kira Biotech is headquartered in Brisbane, Australia.
Which VCs invest in companies like Kira Biotech?
Among active investors with capital left to deploy, Brandon Capital Partners, King River Capital, HEAL Partners and Uniseed back healthcare companies at Kira Biotech's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like Kira Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.